Digital Supported Compression Bandaging in Patients With Chronic Edema in the Lower Limbs (CIMON)

December 19, 2025 updated by: Carsten Bogh Juhl

Digital Supported Compression Bandaging in Patients With Chronic Edema in the Lower Limbs - Assessment of Measurement Properties of a Novel Sensor

Patients with chronic edema of the lower limb referred to compression bandaging in a hospital setting will be invited to participate in the validation study of a novel sensor (CIMON), which have been developed for assessing the effect of compression bandaging. Participants will have the sensor applied to the lower limb before initiation of compression bandaging and will receive usual compression treatment according to severity of the edema and usual practice at the treatment site. Duration of participation is 14 days.

Study Overview

Detailed Description

The CIMON sensor is developed with the purpose of monitoring the effectiveness of compression bandaging (CB) in patients with chronic edema by application to the widest circumference of the calf. CIMON measures the difference in capacitance by stretching the circumferential sensor. Data from the sensor is transferred by Bluetooth technology to a secured webserver, where healthcare professionals can monitor the effect of compression bandaging.

The study aims to assess the psychometric properties of the CIMON (reliability, validity and responsiveness) and assess the correlation between edema reduction and physical activity during compression bandaging.

Study Type

Observational

Enrollment (Actual)

52

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Capital Region
      • Bispebjerg, Capital Region, Denmark
        • Department of Dermatology, Frederiksberg Bispebjerg Hospital
      • Copenhagen, Capital Region, Denmark, 2100
        • Department of Physiotherapy and Occupational Therapy, Rigshospitalet
      • Herlev, Capital Region, Denmark, 2730
        • Department of Physiotherapy and Occupational Therapy, Herlev and Gentofte Hospital
      • Hvidovre, Capital Region, Denmark
        • Department of Physiotherapy and Occupational Therapy, Amager Hvidovre Hospital
    • Region Syddanmark
      • Odense, Region Syddanmark, Denmark
        • Department of Oncology, Unit of Lymphedema care, Odense University Hospital Svendborg

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Patients with chronic edema of the lower limbs referred to compression bandaging in a hospital setting.

Description

Inclusion Criteria:

  • Chronic edema of the lower limb
  • Referred to compression bandaging
  • Circumference of widest point of the lower leg between 35-75 cm

Exclusion Criteria:

  • Wounds at the lower leg (at the widest circumference of the lower leg)
  • Acute deep venous thrombosis in the leg
  • Untreated cellulitis
  • Severe heart- or kidneyfailure
  • Severe peripheral neuropathy in the lower limbs

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients with chronic edema of the lower limbs
Patients with chronic edema of the lower limbs referred to compression bandaging in a hospital setting.
The sensor assess changes in the circumference of the limb and will be applied to the lower limb before compression bandaging is applied.
The sensor assess physical activity and the amount of time spent at rest, standing, walking, running and count steps.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Edema reduction
Time Frame: 14 days
Assessed by Cimon sensor (in capacitans, pF)
14 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Symptoms related to chronic edema
Time Frame: 14 days
Self-reported pain, tension and heaviness
14 days
Adverse events
Time Frame: 14 days
Any adverse events related to compression bandaging and the application of sensors
14 days
Edema reduction
Time Frame: 14 days
Assessed by tape measurement (in cm), converted to volume by formula of truncated cone
14 days
Edema reduction
Time Frame: 14 days
Assessed by perometry (in ml)
14 days
Edema reduction
Time Frame: 14 days
Assessed by Dual energy X-ray Absorptiometry (in kg)
14 days
Physical Activity (PA)
Time Frame: 14 days
Assessed by Sens Motion sensor (PA by sedentary time, low+moderate and high intensity in minutes)
14 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Carsten Bogh Juhl, Professor, Herlev and Gentofte Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 10, 2024

Primary Completion (Actual)

December 18, 2025

Study Completion (Actual)

December 18, 2025

Study Registration Dates

First Submitted

May 27, 2024

First Submitted That Met QC Criteria

May 27, 2024

First Posted (Actual)

May 31, 2024

Study Record Updates

Last Update Posted (Actual)

December 26, 2025

Last Update Submitted That Met QC Criteria

December 19, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Venous Insufficiency

Subscribe